Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
10.44
+0.54 (5.45%)
At close: May 12, 2025, 4:00 PM
10.44
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT

Cartesian Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
180.43212.6176.91106.444.74
Short-Term Investments
---28.16-
Cash & Short-Term Investments
180.43212.6176.91134.64.74
Cash Growth
74.47%176.44%-42.86%2742.70%-
Accounts Receivable
1.770.878.859.763.13
Other Receivables
----0.23
Receivables
1.770.878.859.763.35
Prepaid Expenses
2.923.144.973.490.05
Restricted Cash
---0.29-
Total Current Assets
185.12216.6390.73148.148.14
Property, Plant & Equipment
15.5315.4512.1814.411.5
Long-Term Investments
2222-
Goodwill
48.1648.1648.16--
Other Intangible Assets
150.6150.6150.6--
Other Long-Term Assets
7.722.191.381.340.03
Total Assets
409.13435.02305.05165.899.67
Accounts Payable
2.10.293.150.32-
Accrued Expenses
8.6711.2914.6114.080.79
Current Portion of Long-Term Debt
---8.48-
Current Portion of Leases
3.72.852.171.610.17
Current Unearned Revenue
--2.310.590.12
Other Current Liabilities
0.538.5445.98-0.19
Total Current Liabilities
1522.9868.2125.081.27
Long-Term Debt
---17.79-
Long-Term Leases
10.3611.138.7910.061.11
Long-Term Unearned Revenue
--3.54--
Long-Term Deferred Tax Liabilities
16.1416.1415.85--
Other Long-Term Liabilities
389.42391.58348.2919.140.35
Total Liabilities
430.92441.83444.6872.062.72
Common Stock
0000.02-
Additional Paid-In Capital
692.58689.89179.06493.316.64
Retained Earnings
-709.78-692.07-614.65-394.94-19.61
Comprehensive Income & Other
-4.59-4.62-4.6-4.56-
Total Common Equity
-21.79-6.8-440.1893.83-12.97
Shareholders' Equity
-21.79-6.8-139.6393.836.95
Total Liabilities & Equity
409.13435.02305.05165.899.67
Total Debt
14.0713.9810.9637.931.28
Net Cash (Debt)
166.37198.6365.9696.683.46
Net Cash Growth
78.97%201.15%-31.78%2698.18%-
Net Cash Per Share
7.4311.4412.7619.880.91
Filing Date Shares Outstanding
25.9525.915.4-3.81
Total Common Shares Outstanding
25.9425.775.4-3.81
Working Capital
170.12193.6522.52123.066.87
Book Value Per Share
-0.84-0.26-81.55--
Tangible Book Value
-220.55-205.57-638.9593.83-12.97
Tangible Book Value Per Share
-8.50-7.98-118.38--
Machinery
8.558.157.637.340.78
Construction In Progress
0.480.70.150.6-
Leasehold Improvements
4.083.430.060.06-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q